1. Pal M, Mahendra R. Dermatophytosis - A Highly Infectious Mycosis of Pet Animals. International Journal of Livestock Research. 2017; 7 (1): 1-7.
2. Scorzoni L, Paula de Silva ACA, Marcos CM, Assato PA, de Melo WCMA, de Oliviera HC, et al. Antifungal therapy: New advances in the understanding and treatment of mycosis. Front Microbiol. 2017; 8: 1-23.
3. Ganguly S, Ahmad Para P, Kumar Parveen P. Dermatophyte Examination of Skin Scrapings Collected from a Camel: A Case Study. Inter J Curr Microbiol App Sci. 2017; 6 (2): 1731- 1734.
4. Pakshir K, Hashemi J. Dermatophytosis in Karaj, Iran. Indian Journal of Dermatology. 2006; 51 (4): 262-264.
5. Yamada T, Maeda M, Mahdi Alshahni M, Tanaka R, Yaguchi T, Bontems O, Salamin K, Fratti M, Monod M. Terbinafine resistance of Trichophyton clinical isolates caused by specific point mutations in the squalene epoxidase gene. Antimicrob Agents Chemother. 2017; 61 (7): e00115-17.
6. Salata O. Applications of nanoparticles in biology and medicine. J Nanobiotechnology. 2004. 2:3. DOI: 10.1186/1477-3155-2-3.
7. Dizaj SM, Mennati A, Jafari S, Khezri KH, Adibkia KH. Antimicrobial activity of carbon-based nanoparticles. Adv Pharm Bull. 2015; 5 (1): 19-23.
8. Liakos I, Grumezescu AM, Holban AM. Magnetite nanostructures as novel strategies for anti-infectious Therapy. Molecules. 2014; 19 (8): 12710-12726.
9. Valavanidis A, Vlachogianni T. Engineered Nanomaterials for Pharmaceutical and Biomedical Products New Trends, Benefits and Opportunities. Pharmac Bioprocess. 2016; 4 (1): 3-24.
10. Vlachogianni T, Perdicaris S, Valavanidis A. Engineered Nanomaterials for Biomedical Applications, Pharmaceuticals, Personal Care Products and Skin Protection. Toxicological Problems and Risk Assessment to Humans Pharmakeftiki. 2013; 25 (IV): 109-122.11. DeLouise LA. Applications of Nanotechnology in Dermatology. J Invest Dermatol. 2012; 132 (3 0 2): 964–975.
12. Nasiruddin M, Neyaz MdK, Das Sh. Nanotechnology-Based Approach in Tuberculosis Treatment. Tuberculosis Research and Treatment. 2017; 2017: 4920209.
13. Duttagupta DS, Jadhav VM, Kadam VJ. Chitosan: A propitious biopolymer for drug delivery. Curr Drug Deliv. 2015; 12 (4): 369-81.
14. Youssefi MR, Tabari AM, Moghadamnia, A A. In vitro and in vivo activity of Artemisia sieberi against Trichomonas gallinae. Iran J Vet Res. 2017; 18 (1): 25-29.
15. Behmanesh B, Heshmati GA, Mazandarani M, Rezaei MB, Ahmadi AR, Ghaemi EO, Bakhshande Nosrati S. Chemical Composition and Antibacterial Activity from Essential Oil of Artemisia sieberi Besser subsp. Sieberi in North of Iran. Asian Journal of Plant Sciences. 2007; 6 (3): 562-564.
16. Mehrparvar M. Aphids living on Artemisia and Scorzonera plants (Asteraceae) in Iran: Macrosiphoniella vallesiacae Jörg & Lample, 1988 and Uroleucon pilosellae (Börner, 1933) (Hemiptera:Aphididae) as new records. J Insect Biodivers Syst. 2017; 03 (1): 21-32.
17. Tabari AM, Youssefi MR, Moghaddas E, Ebrahimi MA, Navabi Mousavi N, Naseri A. Antileashmanial activity of Artemisia sieberi essential oil against Leishmania infantum in vitro. Advanced Herbal Medicine. 2016; 2 (2): 40-46.
18. Arun B, Remya VS, Premkumar N, George TP. In vitro antifungal susceptibility of Trichophyton species against itraconazole, ketoconazole and terbinafine. World J Pharmaceu Res. 2015; 4 (4): 1829-1837.
19. Shehata AS, Mukherjee PK, Ghanno MA. Comparison between the standardized clinical and laboratory standards institute M38-A2 method and a 2,3-Bis (2-Methoxy-4-Nitro-5-[ (Sulphenylamino)Carbonyl]-2H-Tetrazolium hydroxide-based method for testing antifungal susceptibility of dermatophytes. Journal of clinical microbiology. 2008; 46 (11): 3668-3671.
20. Rodrigues C, Miranda KC, Fernandes OFL, Soares AJ, Silva MRR. In vitro susceptibility testing of dermatophytes isolated in Goiania, Brazil, against five antifungal agents by broth microdilution method. Rev Inst Med Trop Sao Paulo. 2009; 5 (1): 9-12.
21. Singh J, Zaman M, Gupta AK. Evaluation of microdilution and disk diffusion methods for anti fungal susceptibility testing of dermatophytes. Mycoses. 2007; 45: 595- 602.
22. Ghannoum MA, Long L, Cirino AJ, Miller AR, Najafi R, Wang L, Sharma K, Anderson M, Memarzadeh B. Efficacy of NVC-422 in the treatment of dermatophytosis caused by Trichophyton mentagrophytes using a guinea pig model. Int J Dermatol. 2013; 52 (5): 567-571.
23. Neves CJ, Guerra J, Gamble W. Histopathologic and mycologic aspects of experimental infection of guinea pigs with Microsporum canis. Braz J Vet Res Anim Sci. 2002; 39 (5): 238-243.
24. Shimamura T, Kubota N, Shibuya K. Animal model of dermatophytosis. Journal of Biomedicine and Biotechnology. 2012; 2012: 1-11.
25. Sinha VR, Singla KA. Chitosan microspheres as a potential carrier for drugs. Int J Pharm. 2004; 274 (1-2): 1-33.
26. Ivaškienė M, Matusevičius A, Grigonis A, Zamokas G, Šiugždaitė J. Stablishing the efficacy novel topical formulations in the treatment of experimental dermatophytosis in guinea pigs. Veterinarija Ir Zootechnika (Vet Med Zoot). 2011; T.54 (76): 26-34.
27. Rezaei A, Fazadfard A, Amirahmadi A. An Encyclopedia of Herb-Disease, a Quick Shortcut for Herbal Research: A Comprehension Based on Iranian Herbal Studies. Journal of Biomedical Sciences. 2016; 6 (2:10): 1-8.
28. Niranjan K. In vitro screening of herbal plant extracts on human nail fungus. Vingnanam Journal of Science. 2017; 13 (1,2): 73-77.
29. Gloria KP, Abraham DGI, Kuduk K. Evaluation of Antimycotic activity of crude methanolic extract of Mitrocarpus scaber on Candida albicans and Trichophyton mentagrophytes. Saudi Journal of Medical and Pharmaceutical Sciences. 2017; 3 (3): 217-220.
30. Bhat NA, Bhadwaj A, Tiwari BK. Anti-Dermatophytic Activity Of Catharanthus Roseus L. (Leaves). Int J Inno Res Adv Stud. 2017; 4 (4): 161-165.
31. Farahmand S, Rasooli A, Saffarpour M. Antifungal Activities of Methanolic Extract of Plants. Electronic Journal of Biology. 2016; S1: 42-44.
32. Mashhady Rafie S, Chaharbaradari M, Bayat M. Comparison of therapeutic effects of the Myrtus communis nano-essence and topical 1% terbinafine cream in guinea pigs infected by Microsporum canis.International Research Journal of Biological Sciences. 2014; 3 (3): 23-29.
33. Mashhady Rafie S, Khorram H, Bayat M. Comparison of the Therapeutic Effects of Nano-essence of Medical herb Origanum vulgare with the Ketoconazole 2% Topical cream in Cats Infected by Microsporum canis. International Journal of Biology, Pharmacy and Allied Sciences. 2015; 4 (5): 2855-2865.
34. Mashhady Rafie S, Baradaran AS, Bayat M. Comparison of the therapeutic effects of nano-essence of medical herb Artemisia sieberi with the ointment of ketoconazole in guinea pig infected by Microsporum canis. International Research Journal of Biological Sciences. 2013; 2 (12): 5-10.